GO:0043044 | ATP-dependent chromatin remodeling | 6.77e-05 | 9.77e-01 | 7.293 | 2 | 4 | 23 |
GO:0043022 | ribosome binding | 9.38e-05 | 1.00e+00 | 7.061 | 2 | 3 | 27 |
GO:0031492 | nucleosomal DNA binding | 9.38e-05 | 1.00e+00 | 7.061 | 2 | 4 | 27 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 3.66e-04 | 1.00e+00 | 6.088 | 2 | 5 | 53 |
GO:0043234 | protein complex | 4.40e-04 | 1.00e+00 | 4.196 | 3 | 18 | 295 |
GO:0016020 | membrane | 8.83e-04 | 1.00e+00 | 2.423 | 5 | 90 | 1681 |
GO:0001649 | osteoblast differentiation | 1.10e-03 | 1.00e+00 | 5.293 | 2 | 6 | 92 |
GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0005055 | laminin receptor activity | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0006407 | rRNA export from nucleus | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:1900126 | negative regulation of hyaluronan biosynthetic process | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 2 | 3 |
GO:0071439 | clathrin complex | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 2 | 3 |
GO:0000790 | nuclear chromatin | 2.15e-03 | 1.00e+00 | 4.805 | 2 | 9 | 129 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0030686 | 90S preribosome | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0032051 | clathrin light chain binding | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:1903077 | negative regulation of protein localization to plasma membrane | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0061024 | membrane organization | 2.70e-03 | 1.00e+00 | 4.636 | 2 | 7 | 145 |
GO:0006323 | DNA packaging | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0004596 | peptide alpha-N-acetyltransferase activity | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0000730 | DNA recombinase assembly | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:2000001 | regulation of DNA damage checkpoint | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0031415 | NatA complex | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0030130 | clathrin coat of trans-Golgi network vesicle | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 3 | 6 |
GO:0006474 | N-terminal protein amino acid acetylation | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 6 |
GO:0030957 | Tat protein binding | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 3 | 6 |
GO:0030118 | clathrin coat | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 2 | 6 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 3.48e-03 | 1.00e+00 | 4.450 | 2 | 7 | 165 |
GO:0030132 | clathrin coat of coated pit | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 2 | 7 |
GO:0000028 | ribosomal small subunit assembly | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 7 |
GO:0048096 | chromatin-mediated maintenance of transcription | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 7 |
GO:0006475 | internal protein amino acid acetylation | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 7 |
GO:0008080 | N-acetyltransferase activity | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 1 | 8 |
GO:0070688 | MLL5-L complex | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 1 | 8 |
GO:0070062 | extracellular vesicular exosome | 4.56e-03 | 1.00e+00 | 1.909 | 5 | 104 | 2400 |
GO:0070063 | RNA polymerase binding | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 9 |
GO:0016407 | acetyltransferase activity | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 1 | 10 |
GO:0010569 | regulation of double-strand break repair via homologous recombination | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 1 | 10 |
GO:0071564 | npBAF complex | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 3 | 11 |
GO:0031571 | mitotic G1 DNA damage checkpoint | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 4 | 11 |
GO:0045120 | pronucleus | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 2 | 11 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 2 | 12 |
GO:0071565 | nBAF complex | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 3 | 12 |
GO:0005662 | DNA replication factor A complex | 7.19e-03 | 1.00e+00 | 7.116 | 1 | 1 | 13 |
GO:0021591 | ventricular system development | 7.19e-03 | 1.00e+00 | 7.116 | 1 | 2 | 13 |
GO:0008266 | poly(U) RNA binding | 7.19e-03 | 1.00e+00 | 7.116 | 1 | 1 | 13 |
GO:0046827 | positive regulation of protein export from nucleus | 7.19e-03 | 1.00e+00 | 7.116 | 1 | 3 | 13 |
GO:0035267 | NuA4 histone acetyltransferase complex | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 4 | 14 |
GO:0005730 | nucleolus | 8.01e-03 | 1.00e+00 | 2.136 | 4 | 69 | 1641 |
GO:0016514 | SWI/SNF complex | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 3 | 15 |
GO:0050998 | nitric-oxide synthase binding | 8.84e-03 | 1.00e+00 | 6.816 | 1 | 1 | 16 |
GO:0006337 | nucleosome disassembly | 9.39e-03 | 1.00e+00 | 6.729 | 1 | 3 | 17 |
GO:0035861 | site of double-strand break | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 18 |
GO:0045596 | negative regulation of cell differentiation | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 1 | 20 |
GO:0006298 | mismatch repair | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 3 | 20 |
GO:0005515 | protein binding | 1.12e-02 | 1.00e+00 | 1.067 | 7 | 184 | 6024 |
GO:0032201 | telomere maintenance via semi-conservative replication | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 5 | 21 |
GO:0000718 | nucleotide-excision repair, DNA damage removal | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 4 | 21 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 3 | 22 |
GO:0030863 | cortical cytoskeleton | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 4 | 22 |
GO:0019901 | protein kinase binding | 1.24e-02 | 1.00e+00 | 3.508 | 2 | 21 | 317 |
GO:0043236 | laminin binding | 1.27e-02 | 1.00e+00 | 6.293 | 1 | 1 | 23 |
GO:0001944 | vasculature development | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 24 |
GO:0000722 | telomere maintenance via recombination | 1.38e-02 | 1.00e+00 | 6.172 | 1 | 5 | 25 |
GO:0003730 | mRNA 3'-UTR binding | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 2 | 26 |
GO:0030669 | clathrin-coated endocytic vesicle membrane | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 4 | 28 |
GO:0019894 | kinesin binding | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 1 | 28 |
GO:0005925 | focal adhesion | 1.63e-02 | 1.00e+00 | 3.300 | 2 | 19 | 366 |
GO:0033572 | transferrin transport | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 5 | 30 |
GO:0006271 | DNA strand elongation involved in DNA replication | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 7 | 30 |
GO:0044822 | poly(A) RNA binding | 1.66e-02 | 1.00e+00 | 2.357 | 3 | 49 | 1056 |
GO:0031623 | receptor internalization | 1.71e-02 | 1.00e+00 | 5.862 | 1 | 2 | 31 |
GO:0032947 | protein complex scaffold | 1.71e-02 | 1.00e+00 | 5.862 | 1 | 1 | 31 |
GO:0005654 | nucleoplasm | 1.77e-02 | 1.00e+00 | 2.322 | 3 | 76 | 1082 |
GO:0032588 | trans-Golgi network membrane | 1.87e-02 | 1.00e+00 | 5.729 | 1 | 2 | 34 |
GO:0001895 | retina homeostasis | 1.87e-02 | 1.00e+00 | 5.729 | 1 | 1 | 34 |
GO:0034332 | adherens junction organization | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 36 |
GO:0051084 | 'de novo' posttranslational protein folding | 2.03e-02 | 1.00e+00 | 5.607 | 1 | 4 | 37 |
GO:0048839 | inner ear development | 2.03e-02 | 1.00e+00 | 5.607 | 1 | 2 | 37 |
GO:0006284 | base-excision repair | 2.03e-02 | 1.00e+00 | 5.607 | 1 | 3 | 37 |
GO:0070527 | platelet aggregation | 2.09e-02 | 1.00e+00 | 5.568 | 1 | 2 | 38 |
GO:0022627 | cytosolic small ribosomal subunit | 2.14e-02 | 1.00e+00 | 5.531 | 1 | 4 | 39 |
GO:0000781 | chromosome, telomeric region | 2.14e-02 | 1.00e+00 | 5.531 | 1 | 3 | 39 |
GO:0030136 | clathrin-coated vesicle | 2.31e-02 | 1.00e+00 | 5.424 | 1 | 4 | 42 |
GO:0006892 | post-Golgi vesicle-mediated transport | 2.36e-02 | 1.00e+00 | 5.390 | 1 | 3 | 43 |
GO:0021762 | substantia nigra development | 2.42e-02 | 1.00e+00 | 5.357 | 1 | 2 | 44 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 2.52e-02 | 1.00e+00 | 5.293 | 1 | 7 | 46 |
GO:0044267 | cellular protein metabolic process | 2.65e-02 | 1.00e+00 | 2.927 | 2 | 29 | 474 |
GO:0003684 | damaged DNA binding | 2.69e-02 | 1.00e+00 | 5.201 | 1 | 7 | 49 |
GO:0003725 | double-stranded RNA binding | 2.85e-02 | 1.00e+00 | 5.116 | 1 | 5 | 52 |
GO:0045216 | cell-cell junction organization | 2.96e-02 | 1.00e+00 | 5.061 | 1 | 2 | 54 |
GO:0000724 | double-strand break repair via homologous recombination | 3.01e-02 | 1.00e+00 | 5.035 | 1 | 3 | 55 |
GO:0000723 | telomere maintenance | 3.06e-02 | 1.00e+00 | 5.009 | 1 | 6 | 56 |
GO:0019903 | protein phosphatase binding | 3.39e-02 | 1.00e+00 | 4.862 | 1 | 4 | 62 |
GO:0006302 | double-strand break repair | 3.39e-02 | 1.00e+00 | 4.862 | 1 | 4 | 62 |
GO:0005829 | cytosol | 3.48e-02 | 1.00e+00 | 1.531 | 4 | 132 | 2496 |
GO:0006338 | chromatin remodeling | 3.60e-02 | 1.00e+00 | 4.772 | 1 | 5 | 66 |
GO:0006289 | nucleotide-excision repair | 3.71e-02 | 1.00e+00 | 4.729 | 1 | 11 | 68 |
GO:0034329 | cell junction assembly | 3.71e-02 | 1.00e+00 | 4.729 | 1 | 1 | 68 |
GO:0003697 | single-stranded DNA binding | 3.71e-02 | 1.00e+00 | 4.729 | 1 | 5 | 68 |
GO:0042393 | histone binding | 3.76e-02 | 1.00e+00 | 4.708 | 1 | 1 | 69 |
GO:0006334 | nucleosome assembly | 3.93e-02 | 1.00e+00 | 4.646 | 1 | 2 | 72 |
GO:0060021 | palate development | 3.93e-02 | 1.00e+00 | 4.646 | 1 | 1 | 72 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 4.03e-02 | 1.00e+00 | 4.607 | 1 | 6 | 74 |
GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 4.19e-02 | 1.00e+00 | 4.549 | 1 | 7 | 77 |
GO:0071013 | catalytic step 2 spliceosome | 4.25e-02 | 1.00e+00 | 4.531 | 1 | 4 | 78 |
GO:0019083 | viral transcription | 4.41e-02 | 1.00e+00 | 4.476 | 1 | 10 | 81 |
GO:0005681 | spliceosomal complex | 4.51e-02 | 1.00e+00 | 4.441 | 1 | 4 | 83 |
GO:0006898 | receptor-mediated endocytosis | 4.57e-02 | 1.00e+00 | 4.424 | 1 | 3 | 84 |
GO:0047485 | protein N-terminus binding | 4.67e-02 | 1.00e+00 | 4.390 | 1 | 5 | 86 |
GO:0006415 | translational termination | 4.73e-02 | 1.00e+00 | 4.373 | 1 | 10 | 87 |
GO:0016605 | PML body | 4.78e-02 | 1.00e+00 | 4.357 | 1 | 3 | 88 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 4.89e-02 | 1.00e+00 | 4.324 | 1 | 7 | 90 |
GO:0042470 | melanosome | 4.94e-02 | 1.00e+00 | 4.308 | 1 | 9 | 91 |
GO:0006928 | cellular component movement | 4.94e-02 | 1.00e+00 | 4.308 | 1 | 7 | 91 |
GO:0005200 | structural constituent of cytoskeleton | 4.94e-02 | 1.00e+00 | 4.308 | 1 | 8 | 91 |
GO:0010467 | gene expression | 4.99e-02 | 1.00e+00 | 2.430 | 2 | 59 | 669 |
GO:0006414 | translational elongation | 5.04e-02 | 1.00e+00 | 4.277 | 1 | 13 | 93 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 5.63e-02 | 1.00e+00 | 4.116 | 1 | 10 | 104 |
GO:0014069 | postsynaptic density | 5.68e-02 | 1.00e+00 | 4.102 | 1 | 3 | 105 |
GO:0072562 | blood microparticle | 5.99e-02 | 1.00e+00 | 4.022 | 1 | 3 | 111 |
GO:0030529 | ribonucleoprotein complex | 6.05e-02 | 1.00e+00 | 4.009 | 1 | 8 | 112 |
GO:0005819 | spindle | 6.05e-02 | 1.00e+00 | 4.009 | 1 | 7 | 112 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 6.15e-02 | 1.00e+00 | 3.983 | 1 | 11 | 114 |
GO:0019058 | viral life cycle | 6.20e-02 | 1.00e+00 | 3.971 | 1 | 13 | 115 |
GO:0006325 | chromatin organization | 6.36e-02 | 1.00e+00 | 3.933 | 1 | 5 | 118 |
GO:0006260 | DNA replication | 6.52e-02 | 1.00e+00 | 3.897 | 1 | 9 | 121 |
GO:0006413 | translational initiation | 7.04e-02 | 1.00e+00 | 3.783 | 1 | 17 | 131 |
GO:0031982 | vesicle | 7.04e-02 | 1.00e+00 | 3.783 | 1 | 9 | 131 |
GO:0005634 | nucleus | 7.14e-02 | 1.00e+00 | 0.984 | 5 | 136 | 4559 |
GO:0003735 | structural constituent of ribosome | 7.35e-02 | 1.00e+00 | 3.718 | 1 | 10 | 137 |
GO:0006457 | protein folding | 7.66e-02 | 1.00e+00 | 3.656 | 1 | 7 | 143 |
GO:0000082 | G1/S transition of mitotic cell cycle | 7.97e-02 | 1.00e+00 | 3.597 | 1 | 32 | 149 |
GO:0005198 | structural molecule activity | 8.03e-02 | 1.00e+00 | 3.587 | 1 | 5 | 150 |
GO:0000398 | mRNA splicing, via spliceosome | 8.74e-02 | 1.00e+00 | 3.459 | 1 | 8 | 164 |
GO:0030424 | axon | 8.85e-02 | 1.00e+00 | 3.441 | 1 | 4 | 166 |
GO:0006886 | intracellular protein transport | 9.10e-02 | 1.00e+00 | 3.398 | 1 | 5 | 171 |
GO:0031625 | ubiquitin protein ligase binding | 9.46e-02 | 1.00e+00 | 3.340 | 1 | 14 | 178 |
GO:0005622 | intracellular | 1.09e-01 | 1.00e+00 | 3.123 | 1 | 6 | 207 |
GO:0016071 | mRNA metabolic process | 1.17e-01 | 1.00e+00 | 3.015 | 1 | 31 | 223 |
GO:0007067 | mitotic nuclear division | 1.19e-01 | 1.00e+00 | 2.990 | 1 | 14 | 227 |
GO:0008380 | RNA splicing | 1.20e-01 | 1.00e+00 | 2.983 | 1 | 11 | 228 |
GO:0007399 | nervous system development | 1.21e-01 | 1.00e+00 | 2.964 | 1 | 5 | 231 |
GO:0006412 | translation | 1.21e-01 | 1.00e+00 | 2.971 | 1 | 20 | 230 |
GO:0003713 | transcription coactivator activity | 1.24e-01 | 1.00e+00 | 2.927 | 1 | 10 | 237 |
GO:0016070 | RNA metabolic process | 1.29e-01 | 1.00e+00 | 2.868 | 1 | 32 | 247 |
GO:0005737 | cytoplasm | 1.30e-01 | 1.00e+00 | 0.937 | 4 | 110 | 3767 |
GO:0000166 | nucleotide binding | 1.35e-01 | 1.00e+00 | 2.799 | 1 | 5 | 259 |
GO:0006281 | DNA repair | 1.36e-01 | 1.00e+00 | 2.788 | 1 | 18 | 261 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 1.37e-01 | 1.00e+00 | 2.772 | 1 | 8 | 264 |
GO:0019899 | enzyme binding | 1.44e-01 | 1.00e+00 | 2.702 | 1 | 12 | 277 |
GO:0005856 | cytoskeleton | 1.50e-01 | 1.00e+00 | 2.631 | 1 | 12 | 291 |
GO:0007411 | axon guidance | 1.64e-01 | 1.00e+00 | 2.499 | 1 | 13 | 319 |
GO:0003723 | RNA binding | 1.75e-01 | 1.00e+00 | 2.398 | 1 | 20 | 342 |
GO:0007155 | cell adhesion | 1.87e-01 | 1.00e+00 | 2.289 | 1 | 6 | 369 |
GO:0000278 | mitotic cell cycle | 1.97e-01 | 1.00e+00 | 2.205 | 1 | 48 | 391 |
GO:0007596 | blood coagulation | 2.26e-01 | 1.00e+00 | 1.986 | 1 | 18 | 455 |
GO:0042802 | identical protein binding | 2.39e-01 | 1.00e+00 | 1.897 | 1 | 20 | 484 |
GO:0016032 | viral process | 2.61e-01 | 1.00e+00 | 1.755 | 1 | 55 | 534 |
GO:0045087 | innate immune response | 2.87e-01 | 1.00e+00 | 1.597 | 1 | 24 | 596 |
GO:0005615 | extracellular space | 4.23e-01 | 1.00e+00 | 0.914 | 1 | 17 | 957 |
GO:0005886 | plasma membrane | 4.34e-01 | 1.00e+00 | 0.482 | 2 | 45 | 2582 |
GO:0005524 | ATP binding | 5.30e-01 | 1.00e+00 | 0.474 | 1 | 60 | 1298 |